emoglobinopatie

COVID-19 e impatto sui pazienti con drepanocitosi in Nigeria

COVID-19 e impatto sui pazienti con drepanocitosi in Nigeria

Aliyu Mande, health information officer at Ahmadu Bello Teaching Hospital, Zaria (Nigeria), replied to some questions about the COVID-19 management in his country with a focus on Sickle Cell Disease (SCD) patients. The interview is in the context of the FGB activities within the ARISE project.

leggi di più...
Seconda sessione webinar ARISE su COVID-19 e anemia falciforme

Seconda sessione webinar ARISE su COVID-19 e anemia falciforme

The second session of the webinar, to be held on Thursday 28th May, 2020 at 04:00 PM (UK time), will be the occasion to discuss with some relevant experts in the field to better understand the impact of COVID-19 on the SCD population, drawing conclusions from both the US and Lebanon. The emotional impact of the disease will be addressed as well.

leggi di più...
Covid: impatto sui pazienti con Talassemia e Drepanocitosi

Covid: impatto sui pazienti con Talassemia e Drepanocitosi

COVID-19 pandemic is a health emergency involving all the world and the rare disease community is not excluded. Among the patients exposed to major risks, there are those treated with immunosuppressive drugs and those affected by respiratory diseases, but most of all those who have one or more complications affecting several organs and systems.

leggi di più...